Iris Diseases: Clinical Trials

3 trials for Iris Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3
Phase 21Completed 1

Follow Iris Diseases: new trials by email Literature Review of Iris Diseases trials Research Report on Iris Diseases

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?
Triesence, balanced salt solution BSS - Glaucoma
Phase 2 / Phase 3CompletedWills Eye772009-02-012018-07-10
Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension
SLT, ALT - Exfoliation Syndrome, Ocular Hypertension
Phase 3CompletedUniversity of Calgary252006-09-012010-05-24
24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
travoprost/timolol fixed combination, placebo (artificial tears) - Primary Open Angle Glaucoma, Exfoliation Syndrome
Phase 3CompletedAristotle University Of Thessaloniki322006-03-012014-05-12

Narrower conditions

Exfoliation Syndrome (3)  ·  Glaucoma (2)  ·  Glaucoma, Open-Angle (2)  ·  Glaucoma, Angle-Closure (1)  ·  Glaucoma, Neovascular (1)  ·  Ocular Hypertension (1)

Broader conditions

Eye Diseases (3)  ·  Uveal Diseases (3)  ·  Ocular Hypertension (2)  ·  Glaucoma (1)

Interventions

Hanks Balanced Salt Solution (1)  ·  Lubricant Eye Drops (1)  ·  Travoprost (1)  ·  Triamcinolone (1)

Sponsors

Aristotle University Of Thessaloniki (1)  ·  University of Calgary (1)  ·  Wills Eye (1)

Countries

Canada (1)  ·  Greece (1)  ·  United States (1)

Top investigators

Andrew C Crichton (1)  ·  Marlene R Moster, MD (1)

Results publications

PMID 24794283, PMID 35943114